Polen Capital acquired 22.4 Million Abbott Laboratories shares worth $2.53 Billion. That's 6.21% of their entire equity portfolio (8th largest holding). The investor owns 1.34% of the outstanding Abbott Laboratories stock. The first Abbott Laboratories trade was made in Q3 2013. Since then Polen Capital bought shares fourteen more times and sold shares on eight occasions. The stake costed the investor $1.67 Billion, netting the investor a gain of 51% so far.
Capital International Ltd. CA raised its holdings in shares of Abbott Laboratories (NYSE:ABT) by 16.9% during the second quarter, according to its most recen...Dakota Financial News, 7 months ago
Donations to the Republican Attorneys General Association dipped considerably in the months following the Jan. 6 siege on the U.S. Capitol, records show. Dri...Axios, 10 months ago